Yue Wei

3.1k citations
83 papers · 2.2k indexed · 1 hit paper · h-index 22

Impact in

  • Hematology top 1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immune cells in cancer

Papers in

    • Acute Myeloid Leukemia Research 47
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 10

Yue Wei

77 papers receiving 2.2k citations

Hit Papers

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents 2013 · 539 citations
5392013202620172021100200300400500

Peers

Yue Wei
Comparison fields: 5 of 107
  • Hematology 1.0k
  • Immunology 634
  • Genetics 304
  • Molecular Biology 1.1k
  • Cancer Research 228
Replace Kimberley Joanne Hatfield with:
Kimberley Joanne Hatfield Norway
Shangqin Guo United States
Florian H. Heidel Germany
Alessandro Morotti Italy
Hong‐Hu Zhu China
Mamdooh Gari Saudi Arabia
Shu-Min Xiong China
Elizabeth Calleja United States
Yasunobu Nagata Japan
Jiong Hu China
Yue Wei relative to Kimberley Joanne Hatfield Norway Kimberley Joanne Hatfield's profile →
Citations per field
00.5×1.5×2.0×
Kimberley Joanne Hatfield · 1×
Citations per year

Countries citing papers authored by Yue Wei

Since Specialization
Citations

This map shows the geographic impact of Yue Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Wei more than expected).

Fields of papers citing papers by Yue Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Wei. The network helps show where Yue Wei may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yue Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yue Wei Line = papers co-authored together Yue Wei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20243
3 20240
4 20245
5 20242
6 20236
7 20221
8 20223
9 202261
10 20213
11 201813
12 20188
13 201710
14 201622
15 20166
16 20169
17 201519
18 2015176
19 201340
20 200920

About Yue Wei

Yue Wei is a scholar working on Hematology, Genetics, Cancer Research, Immunology and Molecular Biology, having authored 83 papers that have together received 2.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (47 papers), Epigenetics and DNA Methylation (16 papers), Histone Deacetylase Inhibitors Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), MicroRNA in disease regulation (6 papers), Protein Degradation and Inhibitors (6 papers), Immune cells in cancer (6 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). The work is most often cited by research in Hematology (1.0k citations), Immunology (634 citations), Genetics (304 citations), Molecular Biology (1.1k citations) and Cancer Research (228 citations). Yue Wei has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Guillermo Garcia‐Manero, Hui Yang, Carlos E. Bueso‐Ramos, Irene Gañán‐Gómez, Zhihong Fang, Sherry Pierce, Marcos R. Estecio, Jörge E. Cortes, Masoud Davanlou and Hui Yang. Their work appears in journals such as Blood, Leukemia, Leukemia Research, American Journal of Hematology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026